Comments
Loading...

Scinai Immunotherapeutics Ltd (SCNI) Stock Price, Quote, News & History

SCNINASDAQ
At close: Feb 18, 4:00 PM EST
$0.7514
-0.0143-1.87%
After Hours: 4:08 PM EST
M&A: Recipharm Israel Ltd was acquired by Scinai Immunotherapeutics (SCNI) on Tuesday, February 17, 2026

Key Statistics

Open
$0.77
Close
-
Volume / Avg.
5.43K / 49.17K
Day Range
$0.77 - $0.80
52 Wk Range
0.61 - 6.18
Market Cap
$2.61M
P/E Ratio
0.19
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
1.51%
Days to Cover
1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-5.69M
Investing Cash Flow (TTM)
-16.00K
Financing Cash Flow (TTM)
3.59M
Free Cash Flow (TTM)
-5.71M
Capital Expenditure (TTM)
-16.00K
Net Change in Cash (TTM)
-2.24M

Valuation Metrics

Enterprise Value
$9.65M
PE Ratio (TTM)
0.19
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.88
PB Ratio (TTM)
1.19
Earnings Yield % (TTM)
522.40%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
1.19
Price / EBITDA (TTM)
0.12
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.64

Company Debt

Total Debt
$293.00K
LT Debt
$293.00K
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$989.00K
Debt to Equity
1.06
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.77
Close
-
Volume / Avg.
5.43K / 49.17K
Day Range
$0.77 - $0.80
52 Wk Range
0.61 - 6.18
Market Cap
$2.61M
P/E Ratio
0.19
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
1.51%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH an...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SCNI
DRMA

FAQ

Q

How do I buy Scinai Immunotherapeutics (SCNI) stock?

A

You can purchase shares of Scinai Immunotherapeutics (NASDAQ:SCNI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Scinai Immunotherapeutics (SCNI) competitors?

Q

What is the forecast, or price target, for Scinai Immunotherapeutics (SCNI) stock?

A

There is no analysis for Scinai Immunotherapeutics to provide a consensus price target.

Q

What is the current price for Scinai Immunotherapeutics (SCNI)?

A

The stock price for Scinai Immunotherapeutics (NASDAQ: SCNI) is $0.7514 last updated February 17, 2026 at 4:08 PM EST.

Q

Does Scinai Immunotherapeutics (SCNI) pay a dividend?

A

There are no upcoming dividends for Scinai Immunotherapeutics.

Q

When is Scinai Immunotherapeutics (NASDAQ:SCNI) reporting earnings?

A

Scinai Immunotherapeutics does not have any upcoming earnings scheduled.

Q

Is Scinai Immunotherapeutics (SCNI) going to split?

A

There is no upcoming split for Scinai Immunotherapeutics.

Q

What sector and industry does Scinai Immunotherapeutics (SCNI) operate in?

A

Scinai Immunotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.